Back to Journals

Pathology and Laboratory Medicine International


Dr Zhang

Pathology and Laboratory Medicine, University of Pennsylvania, United States

Dr Zhang

Editor-in-Chief: Dr Paul J. Zhang

Paul J. Zhang is currently a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania and has been practicing pathology in academic institutions for 15 years. Graduating from Guangzhou Medical College in China in 1983, he immigrated to the US in 1985. He was a research associate in Dr. Jack Levin’s laboratory in the Department of Laboratory Medicine, University of California San Francisco, before entering an AP/CP residency program in New York University in 1989. After four years of residency training in NYU, he did a year of intensive fellowship training in oncologic pathology at Sloan Kettering Memorial Cancer Center, New York City, under the chairmanship of world renowned Dr. Juan Rosai from 1993–1994. In 1994, he started his academic career at Roswell Park Cancer Institute, Buffalo, New York, under the Chairmanship of Dr. John J Brooks.  In 1998, he moved to his current institution, the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. During his academic career, he has served as Director of Diagnostic Immunohistochemistry in both Roswell Park and the Hospital of the University of Pennsylvania and published more than 100 peer-reviewed articles in various medical and pathology journals, as well as a number of book chapters, and books.  His research interest has been oncology pathology with the main focus on sarcoma, breast cancer and female genital tract cancer. Applying immunohistochemical, in-situ molecular morphologic and various matrix-based molecular techniques and collaborating with basic scientists and clinical colleagues, his research efforts are mainly focused on translating basic scientific research findings to clinical applications.  The benefits to patient care are reliable biomarkers for cancer diagnosis, prognosis and therapy prediction and a better understanding of cancer biology.     


Editorial Board

Gianfranco D. Alpini, Distinguished Professor, Medical Physiology, Director of Baylor Scott & White DDRC, Central Texas Veterans Health Care Systems, Texas A & M University Health Science Center, Dr. Nicholas C. Hightower Centennial Chair in Gastroenterology Baylor Scott & White, Temple, TX, USA

Adam Bagg, Professor and Director, Hematology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

John S. Brooks, Professor of Pathology and Laboratory Medicine, Chair, Department of Pathology, Pennsylvania Hospital, Philadelphia, PA, USA

Rudolph J. Castellani, Professor of Pathology, Director, Center for Neuropathology, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, MI, USA

Ian Paul Everall, Executive Dean, Institute of Psychiatry, Psychology and Neuroscience at King’s College London, UK

John Goldblum, Professor of Pathology, Cleveland Clinic Lerner College of Medicine, Case Western Reserve; Chairman, Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, USA

Channe D. Gowda, Professor, Department of Biochemistry and Molecular Biology, Pennsylvania State University College of Medicine, Hershey, PA, USA

Masanori Hisaoka, Department of Pathology and Oncology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan

Qin Huang, Director of Research and Development, Department of Pathology and Laboratory Medicine, Boston Veterans Affairs Healthcare System and Harvard Medical School, Boston, USA

Chao-Cheng Huang, Chief, Anatomic Pathology, Department of Pathology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan

Zhong Jiang, Professor of Pathology, Director, Pathology Residency Program, Department of Pathology, Umass Memorial Medical Center, Worcester, MA, USA

Jack Levin, MD, Professor of Laboratory Medicine and Professor of Medicine University of California School of Medicine, San Francisco, USA

Dario Marchetti, Director, Biomarker Research Program, Houston Methodist Research Institute; Professor, Institute of Academic Medicine; Visiting Professor, Department of Molecular and Cellular Biology, Baylor College of Medicine; Member, Houston Methodist Cancer Center, Houston, TX, USA

Elliott Mufson, Ph.D., Director, Alzheimer's Disease Research Laboratory; Professor, Department of Neurobiology, Barrow Neurological Institute, Phoenix, AZ, USA

Irving Nachamkin, Professor of Pathology and Laboratory Medicine, Perelman School of Medicine, Director, Division of Laboratory Medicine and Associate Director, Clinical Microbiology Laboratory, Hospital of University of Pennsylvania, Philadelphia, PA, USA

Vassilios Papadopoulos, Dean, School of Pharmacy, John Stauffer Dean’s Chair in Pharmaceutical Sciences, Professor of Pharmacology & Pharmaceutical Sciences, University of Southern California, Los Angeles, California, USA

Jeremy B. Tuttle, Professor Emeritus (Neuroscience) University of Virginia School of Medicine, Mansfield, CT, USA

George Xu, Departments of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, USA

Bin Yang, Professor of Pathology; Director of Molecular Cytopathology; Co-Director of Women’s Health Fellowship, Pathology & Laboratory Medicine Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA